Vital Signs with Jacob Effron and Nikhil Krishnan

Jacob and Nikhil sit down with Mike Kopko, CEO and co-founder of Pearl Health to discuss Pearl’s care model and what it’s been like building the company as ACO Reach evolved. Mike also shares some great stories negotiating claims in the early days of Oscar.

Jacob and Nikhil sit down with Dr. Jeffrey Kang, CEO of WellBe Senior Medical, and former President of ChenMed, SVP Health and Wellness Solutions at Walgreens, CMO at Cigna, CMO at CMS and CEO of Urban Medical Group. They discuss risk adjustment, retailers in healthcare and how healthcare has/hasn't changed since his work doing risk-based care for complex patients and at CMS in the 80s and 90s.

Jacob and Nikhil sit down with Naomi Allen, CEO and founder of Brightline (child and teen focused mental health company that’s raised >$100M) and Castlight/Livongo exec. They discuss the difficulties of balancing employer customers and employee satisfaction at Castlight, how Livongo captured member delight and Brightline's care model.

Jacob sits down with Geisinger CEO Dr. Jaewon Ryu to discuss how he and Geisinger think about their Fresh Food Farmacy, population-wide DNA sequencing efforts, and transforming medical education.

Jacob sits down with Homeward Health CEO and former Castlight and Livongo CMO Dr. Jenny Schneider to discuss solving provider shortages in rural markets, how tech can/can’t help care and what Livongo did to make coaching more effective.

Jacob and Nikhil sit down with Tomorrow Health CEO and former Oscar Texas GM Vijay Kedar to discuss lessons he learned at Oscar, reflections on the ACA market, the nuances of operationalizing at home care and what Tomorrow is building.

Jacob and Nikhil discuss annual health-tech predictions and are then joined by Thyme Care co-founders Robin Shah and Dr. Bobby Green to discuss the nuances of taking risk in oncology, lessons on selling to providers, and what they're building at Thyme Care. 0:00-9:10 Jacob & Nikhil discussion 9:13-end Thyme Care founders interview with Robin Shah and Dr. Bobby Green

Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.

Jacob sits down with Dr. Arif Nathoo, the CEO of Komodo Health (most recently valued at $3.3B) to discuss Komodo’s journey from a single app to a platform, why EHR data is overhyped and where healthcare data is headed.

Jacob and Nikhil sat down with Dr. Bob Kocher, the Venrock partner who helped write the Affordable Care Act while in the Obama administration to discuss how health systems will increase productivity, what drives healthcare costs, and his reflections on the ACA.